SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-037267
Filing Date
2012-05-15
Accepted
2012-05-15 12:07:42
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12-7157_110q.htm 10-Q 893922
2 EX-31.1 a12-7157_1ex31d1.htm EX-31.1 9187
3 EX-31.2 a12-7157_1ex31d2.htm EX-31.2 9198
4 EX-32.1 a12-7157_1ex32d1.htm EX-32.1 5549
5 EX-32.2 a12-7157_1ex32d2.htm EX-32.2 5560
  Complete submission text file 0001104659-12-037267.txt   3168331

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mack-20120331.xml EX-101.INS 334209
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mack-20120331.xsd EX-101.SCH 22087
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mack-20120331_cal.xml EX-101.CAL 37972
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mack-20120331_def.xml EX-101.DEF 98993
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT mack-20120331_lab.xml EX-101.LAB 335389
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mack-20120331_pre.xml EX-101.PRE 147880
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35409 | Film No.: 12842425
SIC: 2834 Pharmaceutical Preparations